<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="bg">
	<id>http://biseri.zavinagi.org/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Unlynndzom</id>
	<title>Бисери на глупостта - Потребителски приноси [bg]</title>
	<link rel="self" type="application/atom+xml" href="http://biseri.zavinagi.org/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Unlynndzom"/>
	<link rel="alternate" type="text/html" href="http://biseri.zavinagi.org/index.php/%D0%A1%D0%BF%D0%B5%D1%86%D0%B8%D0%B0%D0%BB%D0%BD%D0%B8:%D0%9F%D1%80%D0%B8%D0%BD%D0%BE%D1%81%D0%B8/Unlynndzom"/>
	<updated>2026-05-06T23:50:19Z</updated>
	<subtitle>Потребителски приноси</subtitle>
	<generator>MediaWiki 1.37.0</generator>
	<entry>
		<id>http://biseri.zavinagi.org/index.php?title=Ophthalmic_Products_Pharmaceutics_Ii_Dispensing_Pharmacy_D_Pharm_2nd_Yr_Pdf_Notes&amp;diff=16277</id>
		<title>Ophthalmic Products Pharmaceutics Ii Dispensing Pharmacy D Pharm 2nd Yr Pdf Notes</title>
		<link rel="alternate" type="text/html" href="http://biseri.zavinagi.org/index.php?title=Ophthalmic_Products_Pharmaceutics_Ii_Dispensing_Pharmacy_D_Pharm_2nd_Yr_Pdf_Notes&amp;diff=16277"/>
		<updated>2023-02-10T04:46:04Z</updated>

		<summary type="html">&lt;p&gt;Unlynndzom: Нова страница: „OZURDEX® is a corticosteroid indicated for the remedy of diabetic macular edema. Specific drug interplay research have not been carried out with COMBIGAN®, but think about the potential for an additive or potentiating impact with CNS depressants . Although particular drug interplay research haven't been performed with ALPHAGAN® P, the potential for an additive [https://www.scribd.com/document/624835582/316615Ophthalmic-Medicines-The-Security-And-Efficacy-...“&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;OZURDEX® is a corticosteroid indicated for the remedy of diabetic macular edema. Specific drug interplay research have not been carried out with COMBIGAN®, but think about the potential for an additive or potentiating impact with CNS depressants . Although particular drug interplay research haven't been performed with ALPHAGAN® P, the potential for an additive [https://www.scribd.com/document/624835582/316615Ophthalmic-Medicines-The-Security-And-Efficacy-Of-Brand-name-Versus-Generic-Formulations ophthalmic solution for ears] or potentiating effect with CNS depressants must be thought-about. Click the hyperlinks to go to each product's Indication and Important Safety Information. The soft shell method involves using two totally different OVDs, in appropriate sequence and correct positioning, thus rising value and inconvenience. At low shear rate, corresponding to when the IOL is static, a excessive viscous agent between the lens and the cornea is best at protecting the endothelium from compression by the IOL and likewise provides glorious cushioning to the opening of foldable IOLs inside the attention.&lt;br /&gt;
&lt;br /&gt;
Using Coulter Counter, it's potential to acquire very exact particles’ dimension distribution. Before the measurement, a formulation containing particles have to be suspended in electrolyte, which can cause modifications in composition or variety of particles . Advanced microscopic strategies, corresponding to transmission electron microscopy , scanning electron microscopy , and atomic pressure microscopy , allow high-quality imaging of particles in nanometer decision. TEM and SEM require, however, sturdy samples processing. On the opposite hand, AFM enables capturing the topology of particles’ floor on the picture in nanometer resolution.&lt;br /&gt;
&lt;br /&gt;
LUMIGAN® zero.01% contains benzalkonium chloride, which may be absorbed by and trigger discoloration of soppy contact lenses. Contact lenses should be removed prior to instillation of LUMIGAN® 0.01% and could additionally be reinserted 15 minutes following its administration. Concomitant use of beta-adrenergic blocking brokers with digitalis and calcium antagonists may have additive effects in prolonging atrioventricular conduction time. Observe patients intently when a beta-blocker is run to sufferers receiving catecholamine-depleting medicine as a result of possible additive results and the manufacturing of hypotension and/or marked bradycardia, which may lead to vertigo, syncope, or postural hypotension. Some authorities advocate gradual withdrawal of beta-adrenergic receptor blocking brokers due to impairment of beta-adrenergically mediated reflexes throughout surgical procedure. If needed throughout surgical procedure, the results of beta-adrenergic blocking agents could additionally be reversed by sufficient doses of adrenergic agonists.&lt;br /&gt;
&lt;br /&gt;
Therefore a highly pseudoplastic OVD is fascinating in order that only a relatively mild pressure of injection is required and ocular inflation stress could be judged and modulated by the surgeon’s tactile sensitivity. Viscoadaptive OVDs are substances with excessive molecular weight and high concentration that include fragile long-chain molecules. Their physical properties are completely different from both cohesive and dispersive OVDs. Coating capability is determined primarily by surface pressure and make contact with angle. Surface rigidity refers to the forces appearing on the interface between a viscoelastic agent and a floor. Contact angle is the angle that a drop of substance types with a surface.&lt;br /&gt;
&lt;br /&gt;
One of the primary modifications to conventional forms of ophthalmic medication was introducing polymers to formulation, which enabled longer contact time of energetic ingredient and the corneal surface, thus growing its bioavailability. Next possibility to switch the ophthalmic types lively ingredients’ bioavailability involved introducing excipients to formulation, which enhanced drugs’ penetration into the eyeball. These excipients included chelating agents, surfactants, and cyclodextrins, which, together with energetic components, type inclusion complexes. This will increase solubility, permeability, and bioavailability of poorly soluble medicine [1–4].&lt;br /&gt;
&lt;br /&gt;
Use caution in sufferers topic to spontaneous hypoglycemia or in diabetic patients who are receiving insulin or oral hypoglycemic brokers. Carefully manage patients who might develop thyrotoxicosis to avoid abrupt withdrawal of beta-adrenergic blocking agents that may precipitate a thyroid storm. ALPHAGAN® P 0.1% or zero.15% is an alpha-adrenergic receptor agonist indicated for the reduction of elevated intraocular strain in sufferers with open-angle glaucoma or ocular hypertension. In some prone patients, continued use of topical NSAIDs may result in epithelial breakdown, corneal thinning, corneal erosion, corneal ulceration, or corneal perforation.&lt;br /&gt;
&lt;br /&gt;
In reference to the development of new ophthalmic dosage forms, a problem concerning the evaluation of their physicochemical properties and in vitro-in vivo correlation appears. This paper is a evaluation of the obtainable literature which permits planning research to be conducted on standard and trendy ophthalmic drug varieties. For in vivo launch evaluation, formulations which gave desired leads to in vitro launch evaluations are chosen. Inserts are put in conjunctival sacs of wholesome rabbits chosen for studies. In specified time intervals, inserts are carefully taken out and examined for left drug amount utilizing an appropriate analytic method .&lt;/div&gt;</summary>
		<author><name>Unlynndzom</name></author>
	</entry>
</feed>